Establishment Labs News - ESTA

Company Name	Stock Ticker Symbol	Market	Type
Establishment Labs Holdings Inc	ESTA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	48.54	07:00:01

Open Price	Low Price	High Price	Close Price	Prev Close
				48.54

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/24/2024	08:30	BW	Establishment Labs to Announce First Quarter 2024 Financial..
4/17/2024	08:30	BW	Establishment Labs Announces Participation in The Aesthetic..
3/07/2024	16:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/07/2024	16:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	16:18	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	16:14	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
3/04/2024	08:09	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/01/2024	16:29	EDGAR2	Form NT 10-K - Notification of inability to timely file Form..
2/28/2024	16:20	EDGAR2	Form 8-K - Current report
2/28/2024	16:00	BW	Establishment Labs Reports Fourth Quarter and Full Year 2023..
2/23/2024	08:00	BW	Establishment Labs Announces Participation in Two Upcoming..
2/22/2024	08:00	BW	Establishment Labs Announces Amended Credit Facility with..
2/14/2024	08:00	BW	Establishment Labs to Announce Fourth Quarter 2023 Financial..
2/09/2024	17:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
1/31/2024	16:35	EDGAR2	Form 8-K - Current report
1/31/2024	16:33	EDGAR2	Form 424B7 - Prospectus [Rule 424(b)(7)]
1/24/2024	17:19	EDGAR2	Form D - Notice of Exempt Offering of Securities
1/22/2024	08:00	BW	Establishment Labs Announces Commercial Launch of Motiva..
1/09/2024	16:38	EDGAR2	Form 8-K - Current report
1/09/2024	08:06	BW	Establishment Labs Announces $50 Million Private Placement..
1/08/2024	08:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/08/2024	08:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	19:49	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	08:00	BW	Establishment Labs Announces First U.S. Commercial Procedure..
12/28/2023	08:30	BW	Establishment Labs to Present at the 42nd Annual J.P. Morgan..
12/14/2023	16:12	EDGAR2	Form 8-K - Current report
11/20/2023	08:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/10/2023	08:00	BW	Establishment Labs Announces Participation in Two Upcoming..
11/09/2023	08:00	BW	Establishment Labs Announces National Medical Products..
11/08/2023	16:23	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	16:06	EDGAR2	Form 8-K - Current report
11/07/2023	16:00	BW	Establishment Labs Reports Third Quarter 2023 Financial..
10/25/2023	10:27	BW	Establishment Labs to Announce Third Quarter 2023 Financial..
10/25/2023	08:00	BW	Establishment Labs to Announce Third Quarter 2023 Financial..
10/16/2023	06:00	BW	Establishment Labs Announces FDA Clearance of Motiva Flora..
10/13/2023	08:00	BW	Establishment Labs Announces Two-Year Mia Femtech Clinical..
10/03/2023	16:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/09/2023	17:04	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	16:08	EDGAR2	Form 8-K - Current report
8/08/2023	16:00	BW	Establishment Labs Reports Record Second Quarter 2023..
7/26/2023	08:00	BW	Establishment Labs to Announce Second Quarter 2023 Financial..
7/19/2023	08:00	BW	Establishment Labs Celebrates Opening of Sulàyöm Innovation..
7/05/2023	16:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
5/31/2023	08:00	BW	Establishment Labs to Participate in Two Upcoming Investor..
5/30/2023	08:00	BW	Establishment Labs Announces CE Mark Approval for Minimally..
5/08/2023	16:00	BW	Establishment Labs Reports Record First Quarter 2023..
4/27/2023	10:30	BW	Establishment Labs Announces Closing of Public Offering of..